Concepedia
Publication | Open Access
A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer
158
Citations
19
References
2013
Year
Page 1